Rating History for XORTX Therapeutics (XRTX) by Singular Research

More Stocks Rated by Singular Research | Latest Ratings for XRTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/23/2023 Chris Sakai New Coverage Buy-Venture
(N/A)		 N/A
(N/A)		 0.61
(2.18)		 257.38% Details